Cargando…
Hybrid Imaging for Patient-Specific Dosimetry in Radionuclide Therapy
Radionuclide therapy aims to treat malignant diseases by systemic administration of radiopharmaceuticals, often using carrier molecules such as peptides and antibodies. The radionuclides used emit electrons or alpha particles as a consequence of radioactive decay, thus leading to local energy deposi...
Autores principales: | Ljungberg, Michael, Sjögreen Gleisner, Katarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665601/ https://www.ncbi.nlm.nih.gov/pubmed/26854156 http://dx.doi.org/10.3390/diagnostics5030296 |
Ejemplares similares
-
Personalized Dosimetry for Radionuclide Therapy Using Molecular Imaging Tools
por: Ljungberg, Michael, et al.
Publicado: (2016) -
Feasibility of simplifying renal dosimetry in (177)Lu peptide receptor radionuclide therapy
por: Sundlöv, Anna, et al.
Publicado: (2018) -
SPECT image segmentation for estimation of tumour volume and activity concentration in (177)Lu-DOTATATE radionuclide therapy
por: Gustafsson, Johan, et al.
Publicado: (2017) -
Individualised (177)Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
por: Sundlöv, Anna, et al.
Publicado: (2017) -
Monte Carlo modelling of a compact CZT-based gamma camera with application to (177)Lu imaging
por: Roth, Daniel, et al.
Publicado: (2022)